Gland Pharma Limited Board recommends a final dividend of INR 20 per equity share for the fiscal year ending March 31st, 2024, subject to the approval of its shareholders. The dividend, upon approval by the shareholders, will be paid within 30 days from the date of the 46th Annual General Meeting (AGM). The Record Date for the purpose of the 46th Annual General Meeting and payment of final dividend, if approved by shareholders will be August 16, 2024.